Pieris Pharmaceuticals, Inc. Series F Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTSubscription and Investment Representation Agreement • August 8th, 2024 • Pieris Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionTHIS AGREEMENT, dated as of August 7, 2024, is by and between Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows:
Pieris Pharmaceuticals, Inc. Series F Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTSubscription and Investment Representation Agreement • August 8th, 2024 • Pieris Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionTHIS AGREEMENT, dated as of August 7, 2024, is by and between Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows: